Fadia T Shaya

Summary

Affiliation: University of Maryland
Country: USA

Publications

  1. ncbi request reprint Decision support tools to optimize economic outcomes for type 2 diabetes
    Fadia T Shaya
    University of Maryland School of Pharmacy, 220 Arch St, 12th Floor, Room 01 204, Baltimore, MD, USA
    Am J Manag Care 17:S377-83. 2011
  2. pmc Diabetic retinopathy
    Fadia T Shaya
    Center on Drugs and Public Policy
    Clin Ophthalmol 1:259-65. 2007
  3. ncbi request reprint Comparative and cost effectiveness of treatment modalities for hepatocellular carcinoma in SEER-Medicare
    Fadia T Shaya
    Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, 220 Arch Street, 12th Floor, Baltimore, MD, 21201, USA
    Pharmacoeconomics 32:63-74. 2014
  4. doi request reprint Comparison of physician practice patterns for older adults compared to NHANES diabetes cohort on oral/other therapy
    Fadia T Shaya
    University of Maryland School of Pharmacy, Baltimore, MD, USA
    Expert Rev Pharmacoecon Outcomes Res 13:153-60. 2013
  5. pmc Social networks help control hypertension
    Fadia T Shaya
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    J Clin Hypertens (Greenwich) 15:34-40. 2013
  6. ncbi request reprint Diabetes knowledge in a high risk urban population
    Fadia T Shaya
    Center on Drugs and Public Policy, University of Maryland School of Pharmacy, 515 West Lombard Street, 2nd Floor, Baltimore, MD 21201, USA
    Ethn Dis 21:485-9. 2011
  7. ncbi request reprint The use of age-period-cohort analysis to determine the impact of economic development on COPD mortality in Hong Kong
    Fadia T Shaya
    University of Maryland School of Pharmacy and School of Medicine, 220 Arch Street, Baltimore, MD 21201, USA
    Expert Rev Pharmacoecon Outcomes Res 12:19-21. 2012
  8. ncbi request reprint Bridging the gap between pharmacoeconomics and the real-world practice of managed care pharmacy
    Fadia T Shaya
    University of Maryland School of Pharmacy, 220 Arch St, 12th Fl, Baltimore, MD 21201, USA
    J Manag Care Pharm 13:66-7. 2007
  9. pmc The case for cultural competence in health professions education
    Fadia T Shaya
    Center on Drugs and Public Policy, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    Am J Pharm Educ 70:124. 2006
  10. doi request reprint School-based obesity interventions: a literature review
    Fadia T Shaya
    Center on Drugs and Public Policy, Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    J Sch Health 78:189-96. 2008

Detail Information

Publications53

  1. ncbi request reprint Decision support tools to optimize economic outcomes for type 2 diabetes
    Fadia T Shaya
    University of Maryland School of Pharmacy, 220 Arch St, 12th Floor, Room 01 204, Baltimore, MD, USA
    Am J Manag Care 17:S377-83. 2011
    ..It will also provide guidance on common indices of comorbidity used in health economics research. Data from these models can be used to reduce treatment costs and improve the overall quality of population-level health...
  2. pmc Diabetic retinopathy
    Fadia T Shaya
    Center on Drugs and Public Policy
    Clin Ophthalmol 1:259-65. 2007
    ..Whether these therapies have a clinically significant impact on DR progression however, remains to be seen...
  3. ncbi request reprint Comparative and cost effectiveness of treatment modalities for hepatocellular carcinoma in SEER-Medicare
    Fadia T Shaya
    Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, 220 Arch Street, 12th Floor, Baltimore, MD, 21201, USA
    Pharmacoeconomics 32:63-74. 2014
    ..It remains unclear how medical expenditures vary across patients who remain untreated or undergo different modes of therapy. We evaluate the comparative and cost effectiveness of treatment modalities for HCC from a Medicare perspective...
  4. doi request reprint Comparison of physician practice patterns for older adults compared to NHANES diabetes cohort on oral/other therapy
    Fadia T Shaya
    University of Maryland School of Pharmacy, Baltimore, MD, USA
    Expert Rev Pharmacoecon Outcomes Res 13:153-60. 2013
    ..98; p = 0.07) per additional year of diabetes history. Results suggest that sicker, older patients might benefit from more aggressive therapy, in the context of diabetes prevalence, this is expected to continue rising in that population...
  5. pmc Social networks help control hypertension
    Fadia T Shaya
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    J Clin Hypertens (Greenwich) 15:34-40. 2013
    ..The clustering of patients in social networks around hypertension education has a positive impact on the management of hypertension in minority populations and may help address cardiovascular health disparities...
  6. ncbi request reprint Diabetes knowledge in a high risk urban population
    Fadia T Shaya
    Center on Drugs and Public Policy, University of Maryland School of Pharmacy, 515 West Lombard Street, 2nd Floor, Baltimore, MD 21201, USA
    Ethn Dis 21:485-9. 2011
    ..0104). The study indicated that patients who are exposed to the educational program end up with better knowledge on all counts, than patients who just go through the health care system in the course of usual care for diabetes...
  7. ncbi request reprint The use of age-period-cohort analysis to determine the impact of economic development on COPD mortality in Hong Kong
    Fadia T Shaya
    University of Maryland School of Pharmacy and School of Medicine, 220 Arch Street, Baltimore, MD 21201, USA
    Expert Rev Pharmacoecon Outcomes Res 12:19-21. 2012
    ....
  8. ncbi request reprint Bridging the gap between pharmacoeconomics and the real-world practice of managed care pharmacy
    Fadia T Shaya
    University of Maryland School of Pharmacy, 220 Arch St, 12th Fl, Baltimore, MD 21201, USA
    J Manag Care Pharm 13:66-7. 2007
  9. pmc The case for cultural competence in health professions education
    Fadia T Shaya
    Center on Drugs and Public Policy, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    Am J Pharm Educ 70:124. 2006
    ..Students should be grounded in cultural awareness and cultural sensitivity. This article establishes a case for integrating cultural competence into the curricula of health professions schools...
  10. doi request reprint School-based obesity interventions: a literature review
    Fadia T Shaya
    Center on Drugs and Public Policy, Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    J Sch Health 78:189-96. 2008
    ..This article is an overview of different interventions conducted in school settings so as to guide efforts for an effective management of obesity in children, thus minimizing the risk of adult obesity and related cardiovascular risk...
  11. doi request reprint Burden of concomitant asthma and COPD in a Medicaid population
    Fadia T Shaya
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, 220 Arch St, Twelfth Floor, Baltimore, MD 21201, USA
    Chest 134:14-9. 2008
    ..This study compares utilization outcomes in patients with asthma, COPD, or co-occurring asthma and COPD in a Medicaid population, and assesses the incremental burden of COPD in patients with asthma...
  12. ncbi request reprint Predictors of compliance with antihypertensive therapy in a high-risk medicaid population
    Fadia T Shaya
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, 220 Arch St, 12th Floor, Baltimore, MD 21201, USA
    J Natl Med Assoc 101:34-9. 2009
    ..To identify predictors of compliance with antihypertensive combination therapy in a Medicaid population...
  13. pmc Burden of COPD, asthma, and concomitant COPD and asthma among adults: racial disparities in a medicaid population
    Fadia T Shaya
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    Chest 136:405-11. 2009
    ....
  14. ncbi request reprint Elevated economic burden in obstructive lung disease patients with concomitant sleep apnea syndrome
    Fadia T Shaya
    Department of Pharmaceutical Health Services Research, University of Maryland, Baltimore, MD, 21201, USA
    Sleep Breath 13:317-23. 2009
    ..The purpose of this study is to examine the incremental economic burden of sleep apnea syndrome (SAS) among individuals with concomitant asthma, chronic obstructive pulmonary disease (COPD), or both (i.e., asthma/COPD)...
  15. ncbi request reprint Health-related quality of life as a potential predictor in chronic obstructive lung disease patients
    Fadia T Shaya
    Associate Professor and Associate Director, University of Maryland, Center on Drugs and Public Policy, School of Pharmacy, 220 Arch Street, Room 01 204, Baltimore, MD 21201, USA
    Expert Rev Pharmacoecon Outcomes Res 7:129-35. 2007
    ..Over a 3-month period, no change was seen in the patient-reported health-related quality of life and the change in health-related quality-of-life scores was not associated with disease severity...
  16. doi request reprint US trends in glycemic control, treatment, and comorbidity burden in patients with diabetes
    Fadia T Shaya
    University of Maryland, School of Pharmacy, Pharmaceutical Health Services Research, 220 Arch Street, Baltimore, MD 21201, USA
    J Clin Hypertens (Greenwich) 12:826-32. 2010
    ..The results indicate a high percentage of poor glycemic control among persons with diabetes. There were also a substantial number of comorbid conditions associated with diabetes...
  17. doi request reprint Social networks in cardiovascular disease management
    Fadia T Shaya
    University of Maryland School of Pharmacy, 220 Arch Street, 12th Floor Baltimore, MD 21201, USA
    Expert Rev Pharmacoecon Outcomes Res 10:701-5. 2010
    ..The patient-centered medical home can serve as an adaptive source for social network evolvement...
  18. ncbi request reprint A perspective on African American participation in clinical trials
    Fadia T Shaya
    Center on Drugs and Public Policy, University of Maryland School of Pharmacy, Pharmaceutical Health Services Research, 220 Arch Street, Baltimore, MD 21201, USA
    Contemp Clin Trials 28:213-7. 2007
    ....
  19. ncbi request reprint Formulary decision-making considerations: COX-2 inhibitors
    Fadia T Shaya
    Center on Drugs and Public Policy, University of Maryland School of Pharmacy, Baltimore 21201, USA
    Manag Care Interface 17:29-36, 41. 2004
    ..Particularly in light of recent events, the case of the cyclooxygenase-2 inhibitors for the treatment of arthritis yields interesting perspectives into formulary decision making...
  20. ncbi request reprint Prescription drug spending trends for the privately insured in Maryland, 2000-2001
    Fadia T Shaya
    Center on Drugs and Public Policy at the University of Maryland School of Pharmacy, USA
    Health Aff (Millwood) 23:226-32. 2004
    ..Findings suggest that a greater proportion of the economic burden of prescription drugs in coming years will be borne by those who use them...
  21. ncbi request reprint Assessing potential risks and evaluating expected benefits
    Fadia T Shaya
    Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, School of Medicine, Epidemiology and Preventive Medicine, Baltimore 21201, USA
    Manag Care Interface 18:27-30. 2005
    ..It is unclear how this understanding of treatment benefit and harm should actually relate to a specific clinical decision...
  22. pmc Medicaid managed care: disparities in the use of thiazolidinediones compared with metformin
    Fadia T Shaya
    Outcomes Research Epidemiology Center on Drugs and Public Policy University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    J Natl Med Assoc 97:493-7. 2005
    ..To identify patient characteristics that are associated with the incidence of thiadolidinediones (TZDs) or metformin prescnbing in Medicaid managed care plans...
  23. ncbi request reprint Prescriptions for cyclooxygenase-2 inhibitors and other nonsteroidal anti-inflammatory agents in a medicaid managed care population: African Americans versus Caucasians
    Fadia T Shaya
    Center on Drugs and Public Policy, University of Maryland Baltimore School of Pharmacy, Baltimore, Maryland 21201, USA
    Pain Med 6:11-7. 2005
    ..To determine whether race is a predictor of a patient's likelihood of being prescribed selective cyclooxygenase-2 inhibitors (COX-2s) versus other nonsteroidal anti-inflammatory agents (NSAIDs) in Medicaid managed care plans (MCO)...
  24. ncbi request reprint Selective cyclooxygenase-2 inhibition and cardiovascular effects: an observational study of a Medicaid population
    Fadia T Shaya
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    Arch Intern Med 165:181-6. 2005
    ..This observational cohort study examines the cardiovascular risk of COX-2 inhibitors compared with nonspecific NSAIDs in Maryland Medicaid enrollees, a high-risk population...
  25. ncbi request reprint Addressing cardiovascular disparities through community interventions
    Fadia T Shaya
    Center on Drugs and Public Policy, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    Ethn Dis 16:138-44. 2006
    ..To identify the components and impact of intervention programs aimed at reducing cardiovascular disparities...
  26. ncbi request reprint New treatment approaches to diabetes
    Fadia T Shaya
    University of Maryland School of Pharmacy, Center on Drugs and Public Policy, 515 W Lombard St 256, Baltimore, MD 21201, USA
    Manag Care 15:38, 40-1. 2006
  27. ncbi request reprint Compliance with medicine
    Fadia T Shaya
    Department of Pharmaceutical Health Services Research, Center on Drugs and Public Policy, University of Maryland School of Pharmacy, 515 West Lombard Street, Room 256, Baltimore, MD 21201, USA
    Ophthalmol Clin North Am 18:611-7. 2005
    ..Such results may be best complemented by primary, survey-based data collected from patients in observational studies...
  28. ncbi request reprint Drug therapy persistence and stroke recurrence
    Fadia T Shaya
    Department of Epidemiology and Preventive Medicine, University of Maryland, 515 West Lombard St, Baltimore, MD 21201, USA
    Am J Manag Care 12:313-9. 2006
    ..To assess the effect of persistence of use of warfarin sodium, aspirin, or clopidogrel bisulfate on stroke recurrence in a Medicaid high-risk, largely female, African American population...
  29. ncbi request reprint Comparison of first refill rates among users of sertraline, paroxetine, and citalopram
    C Daniel Mullins
    Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, USA
    Clin Ther 28:297-305; discussion 296. 2006
    ..Research suggests high rates of discontinuation of selective serotonin reuptake inhibitors (SSRIs)...
  30. doi request reprint Transarterial chemoembolization treatment: association between multiple treatments, cumulative expenditures, and survival
    Ian M Breunig
    Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    Value Health 16:760-8. 2013
    ..To examine cumulative survival and Medicaid-paid expenses associated with multiple courses of transarterial chemoembolization (TACE) as primary treatment for hepatocellular carcinoma (HCC)...
  31. pmc The Baltimore Partnership to Educate and Achieve Control of Hypertension (The BPTEACH Trial): a randomized trial of the effect of education on improving blood pressure control in a largely African American population
    Wallace Johnson
    School of Medicine, University of Maryland, Baltimore, MD, USA
    J Clin Hypertens (Greenwich) 13:563-70. 2011
    ..Additional research should be conducted to evaluate whether the use of certified hypertension educators in collaboration with physicians will result in a similar blood pressure reduction...
  32. ncbi request reprint Health care cost of analgesic use in hypertensive patients
    C Daniel Mullins
    Center on Drugs and Public Policy, University of Maryland School of Pharmacy, Baltimore, Maryland, USA
    Clin Ther 26:285-93. 2004
    ..Hypertension is one of the most frequently diagnosed chronic medical conditions in the United States and imposes a substantial financial and social burden on Americans...
  33. doi request reprint Readmissions after unauthorized discharges in the cardiovascular setting
    Eberechukwu Onukwugha
    Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA
    Med Care 49:215-24. 2011
    ....
  34. ncbi request reprint New diagnosis of hypertension among celecoxib and nonselective NSAID users: a population-based cohort study
    Jingshu Wang
    Pharmaceutical Health Services Research Department, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA
    Ann Pharmacother 41:937-43. 2007
    ..However, less is known about how the risk of hypertension is associated with cyclooxygenase 2 selective inhibitors (coxibs), especially celecoxib, the only coxib remaining on the market...
  35. ncbi request reprint Ethnic disparities, hospital quality, and discharges against medical advice among patients with cardiovascular disease
    Ebere Chukwu Onukwugha
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    Ethn Dis 19:172-8. 2009
    ..Disparities in discharges AMA have not been examined among patients with cardiovascular disease, nor has the moderating role of hospital quality been studied...
  36. ncbi request reprint Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram
    C Daniel Mullins
    Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, 21201, USA
    Pharmacotherapy 25:660-7. 2005
    ..To compare persistence, switching, and discontinuation rates among patients taking brand-name selective serotonin reuptake inhibitors (SSRIs)...
  37. doi request reprint Delivering cost-effective care for COPD in the USA: recent progress and current challenges
    Ian M Breunig
    Pharmaceutical Health Services Research, University of Maryland, School of Pharmacy, 220 Arch Street, 12th Floor, Room 01 209, Baltimore, MD 21201, USA
    Expert Rev Pharmacoecon Outcomes Res 12:725-31. 2012
    ..Only then can evidence-based guidelines be translated into the most cost-effective delivery of care...
  38. ncbi request reprint Effect of medication burden on persistent use of lipid-lowering drugs among patients with hypertension
    Teisha A Robertson
    School of Pharmacy, University of Maryland, Baltimore, MD, USA
    Am J Manag Care 14:710-6. 2008
    ..To determine the effect of medication burden on persistent use of newly added lipid-lowering (LL) drugs among patients with hypertension...
  39. ncbi request reprint The burden of obstructive lung disease in Medicaid and managed care populations
    Fadia T Shaya
    University of Maryland School of Pharmacy, Baltimore, MD, USA
    Manag Care 14:20-3; discussion 24-6. 2005
  40. ncbi request reprint Predictors of fixed-dose combination antihypertensive drug therapy in a Medicaid population
    Fadia T Shaya
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, Baltimore, Maryland, USA
    J Am Soc Hypertens 2:469-75. 2008
    ..Sickly male patients were more likely to receive the dual-agent component-based therapy. This information can assist future plans in medication therapy management...
  41. pmc Disparities in prevalence rates for lung, colorectal, breast, and prostate cancers in Medicaid
    C Daniel Mullins
    Center on Drugs and Public Policy, University of Maryland School of Pharmacy, 515 W Lombard St, Second Floor, Baltimore, MD 21201, USA
    J Natl Med Assoc 96:809-16. 2004
    ..Given previous reports of variations in prevalence of cancer in low-income individuals, we sought to determine if disparities in cancer prevalence existed in a similarly-insured Medicaid population...
  42. ncbi request reprint Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus
    C Daniel Mullins
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, 220 Arch Street, Baltimore, MD 21201, USA
    Clin Ther 28:1184-98. 2006
    ..This study compared the cost-effectiveness of linezolid and vancomycin in the treatment of patients with nosocomial pneumonia (NP) caused by methicillin-resistant Staphylococcus aureus (MRSA)...
  43. ncbi request reprint Persistence with overactive bladder pharmacotherapy in a Medicaid population
    Fadia T Shaya
    Center on Drugs and Public Policy, University of Maryland School of Pharmacy, Baltimore, USA
    Am J Manag Care 11:S121-9. 2005
    ....
  44. ncbi request reprint Effect of social networks intervention in type 2 diabetes: a partial randomised study
    Fadia T Shaya
    University of Maryland School of Pharmacy, Baltimore, Maryland, USA
    J Epidemiol Community Health 68:326-32. 2014
    ..In this partially randomised intervention study, we assessed the effect of social networks on the improvement of type 2 diabetes management in a largely African-American population in Baltimore...
  45. doi request reprint The cost effectiveness and budget impact of natalizumab for formulary inclusion
    Justin Bakhshai
    University of Maryland School of Pharmacy, 220 Arch Street, Baltimore, MD 21201, USA
    J Med Econ 13:63-9. 2010
    ..The purpose of this study was to analyze the clinical and economic data associated with natalizumab (Tysabri) and to determine the potential impact of its formulary inclusion in a hypothetical health plan...
  46. ncbi request reprint A qualitative evaluation of a citywide Community Health Partnership program
    C Daniel Mullins
    University of Maryland School of Pharmacy, Department of Pharmaceutical Health Services Research, Saratoga Building, 12th Floor, 220 Arch St, Baltimore, MD 21201, USA
    J Natl Med Assoc 104:53-60. 2012
    ..Through stakeholder engagement, many more communities beyond Baltimore can become better networked to help patients navigate the health care system and improve their health...
  47. doi request reprint Clinical evaluation of natalizumab for formulary consideration
    Ashley Bivins
    University of Maryland School of Pharmacy, Center on Drugs and Public Policy, Baltimore, MD 21201, USA
    Expert Opin Biol Ther 10:1279-87. 2010
    ..Evaluation of natalizumab's clinical relevance must be performed before considering its place in treatment of these diseases...
  48. ncbi request reprint Effect of initial ziprasidone dose on treatment persistence in schizophrenia
    C Daniel Mullins
    University of Maryland School of Pharmacy, 515 W Lombard Street, Room 262, Baltimore, MD 21201, United States
    Schizophr Res 83:277-84. 2006
    ..To determine the relationship between ziprasidone initial dose and treatment persistence among patients diagnosed with schizophrenia...
  49. doi request reprint Clinical value of tapentadol extended-release in painful diabetic peripheral neuropathy
    Bansri Desai
    University of Maryland School of Pharmacy, 300 West Lombard St, Apt 413, Baltimore, MD 21201, USA
    Expert Rev Clin Pharmacol 7:203-9. 2014
    ..The purpose of this review article is to assess the efficacy and safety of tapentadol extended-release in adult populations with painful diabetic peripheral neuropathy and provide guidance for formulary decisions. ..
  50. pmc Utilizing new prescription drugs: disparities among non-Hispanic whites, non-Hispanic blacks, and Hispanic whites
    Junling Wang
    Division of Health Science Administration, Department of Pharmaceutical Sciences, University of Tennessee College of Pharmacy, 847 Monroe Ave, Room 205R, Memphis, TN 38163, USA
    Health Serv Res 42:1499-519. 2007
    ..To examine racial and ethnic disparities in new prescription drug use...
  51. ncbi request reprint Disparities in access to essential new prescription drugs between non-Hispanic whites, non-Hispanic blacks, and Hispanic whites
    Junling Wang
    University of Tennessee College of Pharmacy, USA
    Med Care Res Rev 63:742-63. 2006
    ..Disparities exist in new, essential drug acquisition between non-Hispanic whites and non-Hispanic blacks. Socioeconomic and health characteristics explain many of the observed disparities...
  52. ncbi request reprint Discontinuation rates of topical glaucoma medications in a managed care population
    Fadia T Shaya
    Am J Manag Care 8:S271-7. 2002
    ..Rates of medication discontinuation reflect factors including effectiveness, tolerability, cost, and dosing frequency. Discontinuation data can be useful to physicians and health plan managers as they compare various glaucoma medications...
  53. ncbi request reprint Summary quality scores for pharmacoeconomic studies: balancing validity with need
    Fadia T Shaya
    J Manag Care Pharm 9:87-8. 2003